Structural Analysis and Development of Notum Fragment Screening Hits.
Zhao, Y., Mahy, W., Willis, N.J., Woodward, H.L., Steadman, D., Bayle, E.D., Atkinson, B.N., Sipthorp, J., Vecchia, L., Ruza, R.R., Harlos, K., Jeganathan, F., Constantinou, S., Costa, A., Kjaer, S., Bictash, M., Salinas, P.C., Whiting, P., Vincent, J.P., Fish, P.V., Jones, E.Y.(2022) ACS Chem Neurosci 13: 2060-2077
- PubMed: 35731924 
- DOI: https://doi.org/10.1021/acschemneuro.2c00325
- Primary Citation of Related Structures:  
7B4X, 7B84, 7B86, 7B87, 7B89, 7B8C, 7B8D, 7B8F, 7B8G, 7B8J, 7B8K, 7B8L, 7B8M, 7B8N, 7B8O, 7B8U, 7B8X, 7B8Y, 7B8Z, 7B98, 7B99, 7B9D, 7B9I, 7B9N, 7B9U, 7BA1, 7BAC, 7BAP, 7BC8, 7BC9, 7BCC, 7BCD, 7BCF, 7BCH, 7BCI, 7BCK, 7BCL, 7BD2, 7BD3, 7BD4, 7BD5, 7BD6, 7BD8, 7BD9, 7BDA, 7BDB, 7BDC, 7BDD, 7BDF, 7BDG - PubMed Abstract: 
The Wnt signaling suppressor Notum is a promising target for osteoporosis, Alzheimer's disease, and colorectal cancers. To develop novel Notum inhibitors, we used an X-ray crystallographic fragment screen with the Diamond-SGC Poised Library (DSPL) and identified 59 fragment hits from the analysis of 768 data sets ...